ZA905654B - A method for preparing a pharmaceutical composition in the form of microparticles - Google Patents

A method for preparing a pharmaceutical composition in the form of microparticles

Info

Publication number
ZA905654B
ZA905654B ZA905654A ZA905654A ZA905654B ZA 905654 B ZA905654 B ZA 905654B ZA 905654 A ZA905654 A ZA 905654A ZA 905654 A ZA905654 A ZA 905654A ZA 905654 B ZA905654 B ZA 905654B
Authority
ZA
South Africa
Prior art keywords
microparticles
preparing
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA905654A
Other languages
English (en)
Inventor
Piero Orsolini
Orsolini Piero
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Publication of ZA905654B publication Critical patent/ZA905654B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA905654A 1989-07-28 1990-07-18 A method for preparing a pharmaceutical composition in the form of microparticles ZA905654B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2829/89A CH679207A5 (enExample) 1989-07-28 1989-07-28

Publications (1)

Publication Number Publication Date
ZA905654B true ZA905654B (en) 1991-05-29

Family

ID=4242536

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA905654A ZA905654B (en) 1989-07-28 1990-07-18 A method for preparing a pharmaceutical composition in the form of microparticles

Country Status (23)

Country Link
US (1) US5134122A (enExample)
JP (1) JPH0662427B2 (enExample)
AT (1) AT397197B (enExample)
AU (1) AU619996B2 (enExample)
BE (1) BE1003093A3 (enExample)
CA (1) CA2021767C (enExample)
CH (1) CH679207A5 (enExample)
DE (1) DE4023134C2 (enExample)
DK (1) DK175495B1 (enExample)
ES (1) ES2020890A6 (enExample)
FI (1) FI97688C (enExample)
FR (1) FR2650182B1 (enExample)
GB (1) GB2234169B (enExample)
GR (1) GR1001215B (enExample)
IE (1) IE65397B1 (enExample)
IL (1) IL95120A (enExample)
IT (1) IT1243357B (enExample)
LU (1) LU87772A1 (enExample)
NL (1) NL194858C (enExample)
NO (1) NO300304B1 (enExample)
PT (1) PT94842B (enExample)
SE (1) SE504279C2 (enExample)
ZA (1) ZA905654B (enExample)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
CH681425A5 (enExample) * 1990-11-14 1993-03-31 Debio Rech Pharma Sa
DK0528978T3 (da) * 1990-05-16 2003-02-17 Southern Res Inst Mikrokapsler til reguleret afgivelse og deres anvendelse i stimulering af nervefibervækst
US6517859B1 (en) 1990-05-16 2003-02-11 Southern Research Institute Microcapsules for administration of neuroactive agents
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
US5569468A (en) * 1994-02-17 1996-10-29 Modi; Pankaj Vaccine delivery system for immunization, using biodegradable polymer microspheres
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
FR2748205A1 (fr) 1996-05-06 1997-11-07 Debio Rech Pharma Sa Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
CA2267930A1 (en) * 1996-10-09 1998-04-16 Nobuyuki Takechi A method for producing a microparticle
WO1998032423A1 (en) * 1997-01-29 1998-07-30 Takeda Chemical Industries, Ltd. Sustained-release microspheres, their production and use
US6071982A (en) * 1997-04-18 2000-06-06 Cambridge Scientific, Inc. Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
EP1028746B1 (en) 1997-11-07 2003-02-26 Chiron Corporation Method for producing igf-i sustained-release formulations
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
US6455526B1 (en) 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
HK1041645B (zh) * 1998-12-16 2005-07-29 Aventisub Ii Inc. 生物可降解聚合物包封的5-羟色胺受体拮抗剂及其制备方法
ATE297190T1 (de) 1999-02-26 2005-06-15 Chiron Corp Mikroemulsionen mit adsorbierten makromolekülen und mikropartikeln
US7713739B1 (en) * 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
ES2169980B1 (es) 1999-12-17 2003-11-01 Lipotec Sa Microcapsulas para la liberacion prolongada de farmacos.
US6362308B1 (en) 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
CA2444894C (en) * 2001-04-26 2013-06-25 Control Delivery Systems, Inc. Sustained release drug delivery system containing codrugs
ES2290294T3 (es) * 2001-05-23 2008-02-16 Hexal Ag Procedimiento para la fabricacion de implantes por medio de la preparacion libre de disolventes de un producto homogeneizado.
JP2004535431A (ja) 2001-06-22 2004-11-25 サザン バイオシステムズ， インコーポレイテッド ゼロ次長期放出同軸インプラント
IN2014DN10834A (enExample) * 2001-09-17 2015-09-04 Psivida Inc
AU2003244157A1 (en) * 2002-06-25 2004-01-06 Takeda Pharmaceutical Company Limited Process for producing sustained-release composition
DK2246360T3 (da) 2003-01-28 2012-08-13 Ironwood Pharmaceuticals Inc Sammensætninger til behandlingen af gastrointestinale lidelser
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
GB0304726D0 (en) * 2003-03-01 2003-04-02 Ardana Bioscience Ltd New Process
EP1617859A1 (en) * 2003-04-30 2006-01-25 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone
US9149440B2 (en) * 2003-09-02 2015-10-06 University Of South Florida Nanoparticles for drug-delivery
WO2005044817A1 (en) 2003-11-05 2005-05-19 Sunesis Pharmaceuticals, Inc. Modulators of cellular adhesion
WO2005063276A1 (en) * 2003-12-23 2005-07-14 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
WO2006026731A1 (en) 2004-08-30 2006-03-09 Spineovations, Inc. Method of treating spinal internal disk derangement
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
CA2960117C (en) * 2005-05-17 2018-01-30 Sarcode Bioscience Inc. Lfa-1 antagonists for the treatment of eye disorders
KR100722607B1 (ko) 2006-05-11 2007-05-28 주식회사 펩트론 분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
RS58248B1 (sr) * 2007-06-06 2019-03-29 Debiopharm Res & Manufacturing Sa Farmaceutska kompozicija sa sporim oslobađanjem pripremljena od mikročestica
EP2209371B1 (en) 2007-10-19 2017-01-04 SARcode Bioscience Inc. Compositions and methods for treatment of diabetic retinopathy
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US8469961B2 (en) * 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US20100010549A1 (en) * 2008-03-05 2010-01-14 Neville Alleyne device and method of minimally invasive extracapsular ligamentous augmentation for canine stifle ligament injuries
CN102065893A (zh) * 2008-04-15 2011-05-18 萨可德公司 Lfa-1拮抗剂向胃肠系统的递送
WO2009139817A2 (en) 2008-04-15 2009-11-19 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2421517A4 (en) * 2009-04-23 2013-08-07 Sustained Nano Systems Llc DONATION DEVICE WITH CONTROLLED OUTPUT
US8378105B2 (en) 2009-10-21 2013-02-19 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
KR101411349B1 (ko) 2010-12-24 2014-06-25 주식회사 삼양바이오팜 생리활성 펩타이드를 포함하는 마이크로입자 및 그의 제조방법, 및 그를 포함하는 약제학적 조성물
WO2012151343A1 (en) 2011-05-04 2012-11-08 Balance Therapeutics, Inc. Pentylenetetrazole derivatives
EP2630964A1 (en) 2012-02-22 2013-08-28 Immundiagnostik AG Method and medicament for treating patients in risk of prediabetes and type-2 diabetes
US10071061B2 (en) 2012-05-14 2018-09-11 Teijin Limited Sterile composition
KR102157608B1 (ko) 2012-07-25 2020-09-18 에스에이알코드 바이오사이언스 인코포레이티드 Lfa-1 저해제 및 그의 다형체
HK1218629A1 (zh) 2013-02-25 2017-03-03 Bausch Health Ireland Limited 用於结肠清洁的鸟苷酸环化酶受体激动剂
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
RU2016114805A (ru) * 2013-10-08 2017-11-15 Ферринг Бв Микрочастицы, содержащие GnRH, изготовленные посредством PGSS (образования частиц в насыщенных газом растворах)
WO2015054649A2 (en) 2013-10-10 2015-04-16 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
SG10201906601TA (en) 2015-01-16 2019-09-27 Spineovations Inc Method of treating spinal disk
US10653744B2 (en) 2016-01-11 2020-05-19 Bausch Health Ireland Limited Formulations and methods for treating ulcerative colitis
MX2020000376A (es) 2017-07-11 2020-07-14 Sustained Nano Systems Llc Formulaciones farmaceuticas hipercomprimidas.
AU2018300071B2 (en) 2017-07-11 2024-09-19 Sustained Nano Systems Llc Radiation sterilization of hypercompressed polymer dosage forms
WO2019066649A1 (en) 2017-09-26 2019-04-04 Nanomi B.V. PROCESS FOR THE PREPARATION OF MICROPARTICLES BY A DOUBLE EMULSION TECHNIQUE
WO2021185373A1 (zh) * 2020-03-20 2021-09-23 苏州医本生命科技有限公司 载药用微粒、载药微粒、蓄粒管及其植入系统
WO2024250012A2 (en) 2023-06-02 2024-12-05 33 Medical, Inc. Compositions for treatment of discogenic pain, and processes for making and using the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3976071A (en) * 1974-01-07 1976-08-24 Dynatech Corporation Methods of improving control of release rates and products useful in same
US3978203A (en) * 1974-07-12 1976-08-31 Dynatech Corporation Sustained release of pharmaceuticals from polyester matrices
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4483807A (en) * 1981-01-27 1984-11-20 Japan Atomic Energy Research Institute Process for producing a slow release composite
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH661206A5 (fr) * 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
JPS60181029A (ja) * 1984-02-29 1985-09-14 Toyo Jozo Co Ltd 徐放性製剤の製法
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
IL79134A (en) * 1985-07-29 1991-06-10 American Cyanamid Co Continuous release peptide implants for parenteral administration
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
JPS63218632A (ja) * 1987-03-06 1988-09-12 Japan Atom Energy Res Inst ホルモンに徐放性機能を付与した生体分解型コポリ（グルコ−ル酸／ｌ−乳酸）複合体の製造方法
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
DE3734223A1 (de) * 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem

Also Published As

Publication number Publication date
IL95120A0 (en) 1991-06-10
CA2021767C (en) 1996-10-22
AU5910390A (en) 1991-01-31
IE65397B1 (en) 1995-10-18
GB2234169A (en) 1991-01-30
NO903264L (no) 1991-01-29
NO300304B1 (no) 1997-05-12
GR900100568A (en) 1991-12-10
ATA154590A (de) 1993-07-15
NO903264D0 (no) 1990-07-23
FI97688B (fi) 1996-10-31
IT9021019A0 (it) 1990-07-23
PT94842B (pt) 1997-04-30
NL9001646A (nl) 1991-02-18
DK180790D0 (da) 1990-07-27
NL194858C (nl) 2003-05-06
ES2020890A6 (es) 1991-10-01
DK175495B1 (da) 2004-11-08
GB9015722D0 (en) 1990-09-05
IT9021019A1 (it) 1992-01-23
FR2650182A1 (fr) 1991-02-01
IE902592A1 (en) 1991-02-27
SE9002522L (sv) 1991-01-29
AU619996B2 (en) 1992-02-06
GB2234169B (en) 1993-02-10
FI97688C (fi) 1997-02-10
SE504279C2 (sv) 1996-12-23
JPH0366625A (ja) 1991-03-22
IL95120A (en) 1994-10-07
DE4023134C2 (de) 1997-04-17
GR1001215B (el) 1993-06-21
FR2650182B1 (fr) 1992-05-15
DE4023134A1 (de) 1991-01-31
CH679207A5 (enExample) 1992-01-15
BE1003093A3 (fr) 1991-11-19
AT397197B (de) 1994-02-25
LU87772A1 (fr) 1990-12-11
JPH0662427B2 (ja) 1994-08-17
FI903643A0 (fi) 1990-07-19
NL194858B (nl) 2003-01-06
US5134122A (en) 1992-07-28
PT94842A (pt) 1991-03-20
DK180790A (da) 1991-01-29
IT1243357B (it) 1994-06-10
CA2021767A1 (en) 1991-01-29
SE9002522D0 (sv) 1990-07-27

Similar Documents

Publication Publication Date Title
GB9015722D0 (en) A method for preparing a pharmaceutical composition in the form of microparticles
GB9005730D0 (en) Solid pharmaceutical composition and a process for preparing same
ZA895588B (en) Intravenou pharmaceutical composition and process for preparing the same
HUT58326A (en) Process for producing pipeidine derivatives and pharmaceutical compositions containing them
HUT48900A (en) Process for producing phosphoruus-containing squalene-synthetase inhibitores and pharmaceutical compositions containing them
HUT53644A (en) Process for producing pharmaceutical nukleozides and pharmaceutical compositions containing them
HUT53102A (en) Process for producing new quinuclidine derivatives and pharmaceutical compositions comprising same
EG18603A (en) A method for the preparation of pharmaceutical composition
HUT58304A (en) Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them
HUT57237A (en) Process for producing glucosaminoglucanic salts and pharmaceutical compositions comprising same
GR900100569A (el) Μέ?οδος παρασκευής ενώσεως για χορήγηση δια του στόματος περιεχούσης NAC.
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
GB8924286D0 (en) Pharmaceutical composition and process for preparing the same
HUT56078A (en) Process for producing piridazine derivatives and pharmaceutical compositions containing them
HU906358D0 (en) Process for producing nukleosides and pharmaceutical compositions containing them
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
PL285753A1 (en) Method for manufacturing indenoindolo compounds and a pharmaceutical composition
HUT53620A (en) Process for producing new thiouracyl derivatives and pharmaceutical compositions comprising same
EP0430025A3 (en) Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
EP0418020A3 (en) Cephalosporinderivatives, process for their preparation and pharmaceutical compositions
CS222291A3 (en) Solid pharmaceutical mixtures and process for preparing thereof
HUT54165A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising same
GR900100491A (en) Acaricidel compositions and process for preparing same
EP0423686A3 (en) Silacyclobutanes and process for preparation
HUT55636A (en) Process for producing pharmaceutical composition